Company Filing History:
3 out of 156 
1 out of 872 
Years Active: 1991-1993
Title: Innovations by Jean-Luc E Vanderheyden
Introduction
Jean-Luc E Vanderheyden is a notable inventor based in Seattle, WA. He has made significant contributions to the field of medical imaging and cancer therapy, particularly focusing on bone-related conditions. With a total of 3 patents, Vanderheyden's work has the potential to impact diagnostic and therapeutic practices in oncology.
Latest Patents
One of Vanderheyden's latest patents is centered around conjugates for bone imaging and bone cancer therapy. This invention provides conjugates formed from calcified tissue targeting agents and radiolabeled compounds. One such conjugate comprises a chelate and a targeting agent capable of associating with calcified tissue. The chelate contains at least one nitrogen atom or at least one sulfur atom, or combinations thereof, as the donor atoms. Another aspect of the invention outlines methods for using these conjugates for diagnostic and therapeutic purposes, particularly in relation to bone cancer.
Career Highlights
Throughout his career, Vanderheyden has worked with reputable organizations, including Neorx Corporation and the University of Missouri. His experience in these institutions has allowed him to develop innovative solutions in the medical field.
Collaborations
Vanderheyden has collaborated with notable colleagues such as Alan R Fritzberg and Sudhakar Kasina. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Jean-Luc E Vanderheyden's contributions to medical imaging and cancer therapy demonstrate his commitment to innovation in healthcare. His patents reflect a deep understanding of the complexities involved in diagnosing and treating bone-related conditions.